ARC-HBR Bleeding vs. Thrombosis Tradeoff
Risk Factors
Demographics & Lab Values
Clinical Factors
Procedure & Medication
1-Year Predicted Risk
BARC 3-5 Bleeding
1.40%
MI / Stent Thrombosis
1.40%
Bleeding dominates
Equal
Ischemia dominates
Enter risk factors to see the tradeoff analysis.
Active Bleeding Factors:
- None
Active Thrombotic Factors:
- None
Clinical Interpretation
- Ischemia > Bleeding: Consider extending/intensifying antithrombotic therapy
- Bleeding > Ischemia: Consider shortening/simplifying antithrombotic therapy
- Balanced: Standard guideline-based DAPT duration
Citation
Title: Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model
Authors: Urban P, Gregson J, Owen R, Mehran R, et al.
Journal: JAMA Cardiology, 2021;6(4):410-419